arXivDaily arXiv每日学术速递 周一至周五更新
arXiv周末暂无论文更新,休息一下吧,周末愉快~~
arXiv 2404.11802stat.AP
收藏

Medicaid患者中疼痛管理治疗与阿片类药物使用障碍风险的关联

Associations between pain-management treatments and opioid use disorder risk among Medicaid patients

Kara E. Rudolph, Nicholas T. Williams, Ivan Diaz, Sarah Forrest, Katherine L. Hoffman, Hillary Samples, Mark Olfson, Lisa Doan, Magdalena Cerda, Rachael Ross

AI总结:

本研究针对Medicaid慢性疼痛患者,分析9种疼痛管理治疗与新发OUD的关联,发现阿片类与加巴喷丁或苯二氮䓬类联用、阿片类剂量及时长均升高OUD风险,物理治疗可降低无残疾患者的OUD风险。

摘要:

引言:慢性疼痛患者的阿片类药物滥用风险更高。由于各类疼痛管理治疗通常联合实施,其独立效应存在混杂,目前人们对每种治疗带来的独特风险了解较少。我们在控制基线人口统计学和临床混杂变量、并将其他疼痛管理治疗维持在观测水平的前提下,评估了慢性疼痛患者的疼痛管理策略与新发阿片类药物使用障碍(OUD)风险的关联程度。\n方法:我们使用了2016-2019年来自25个州、年龄在35-64岁的非妊娠Medicaid患者队列中的两个慢性疼痛亚组数据:1)伴有身体残疾共病的慢性疼痛患者(N=6133),2)无残疾的慢性疼痛患者(N=67438)。我们纳入了9种疼痛管理治疗:处方阿片类药物的i)剂量和ii)持续时间;iii)阿片类药物处方医生数量;阿片类药物与iv)苯二氮䓬类、v)肌肉松弛剂、vi)加巴喷丁类药物的联合处方;vii)非阿片类疼痛处方药、viii)物理治疗、ix)其他疼痛治疗方式。研究结局为新发OUD。\n结果:阿片类药物与加巴喷丁联合处方,或阿片类药物与苯二氮䓬类联合处方,与OUD风险升高16%-46%具有统计学显著关联。阿片类药物的剂量和持续时间也与OUD风险升高显著相关。在无残疾的慢性疼痛亚组中,物理治疗与OUD风险降低11%显著相关。\n结论:阿片类药物与加巴喷丁或苯二氮䓬类的联合处方可能会大幅增加OUD风险。更积极的是,物理治疗可能是一种相对易得且安全的疼痛管理策略。

英文摘要:

Introduction: Chronic pain patients are at increased risk of opioid-misuse. Less is known about the unique risk conferred by each pain-management treatment, as treatments are typically implemented together, confounding their independent effects. We estimated the extent to which pain-management strategies were associated with risk of incident opioid use disorder (OUD) for those with chronic pain, controlling for baseline demographic and clinical confounding variables and holding other pain-management treatments at their observed levels. Methods: We used data from two chronic pain subgroups within a cohort of non-pregnant Medicaid patients aged 35-64 years, 2016-2019, from 25 states: 1) those with a chronic pain condition co-morbid with physical disability (N=6,133) or 2) those with chronic pain without disability (N=67,438). We considered 9 pain-management treatments: prescription opioid i) dose and ii) duration; iii) number of opioid prescribers; opioid co-prescription with iv) benzodiazepines, v) muscle relaxants, and vi) gabapentinoids; vii) non-opioid pain prescription, viii) physical therapy, and ix) other pain treatment modality. Our outcome was incident OUD. Results: Having an opioid and gabapentin co-prescription or an opioid and benzodiazepine co-prescription was statistically significantly associated with a 16-46% increased risk of OUD. Opioid dose and duration also were significantly associated with increased risk of OUD. Physical therapy was significantly associated with an 11% decreased risk of OUD in the subgroup with chronic pain but no disability. Conclusions: Co-prescription of opioids with either gabapentin or benzodiazepines may substantially increase risk of OUD. More positively, physical therapy may be a relatively accessible and safe pain-management strategy.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑